In response to the FDA request, there is a demonstrated duration of CR of 13.2% (9/68) at 540 days, 8.8% (6/68) at 630 days, 7.4% (5/68) at 720 days, 7.4% (5/68) at 900 days and 5.9% (4/68) at 1080 ...

A recent study published in the New England Journal of Medicine and found no significant survival benefit of extended ...

The SWOG S1011 trial shows no survival benefit from extended lymphadenectomy in bladder cancer, revealing higher complications and mortality post-surgery.

The SWOG S1011 randomized phase 3 trial found no significant improvement in disease-free or overall survival but a higher ...

Final results from the SWOG S1011 randomized Phase III clinical trial, published in the New England Journal of Medicine, ...

The SWOG S1011 randomized phase 3 trial found no significant improvement in disease-free or overall survival but a higher ...

A YOUNG woman has revealed how she pees through her belly button after a devastating car accident left her paralysed Steph Aiello, from California, US, was due to start make-up artists training in ...

Photocure ASA (OSE: PHO), the Bladder Cancer Company, announces that its partner Asieris Pharmaceuticals (SSE: 688176) communicated that international multicenter Phase III clinical study data for its ...

U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in ...

Ultimately, the real test lies in personal experience. With its unique formulation and positive user testimonials, FemiPro ...

UChicago Medicine has become the first medical center in Illinois to implant the Revi neuromodulation device, an exciting new ...

Self-care with overactive bladder involves making lifestyle changes, taking medications, going to physical therapy, and ...